PMI says Colorado ZYN plant build advances as first pouches hit market in 2025

Feb.10

Philip Morris International (PMI) is investing $600 million to build a ZYN nicotine pouch plant in Aurora, Colorado. While the facility is still under construction, PMI said production started in September 2025 and the first pouches made at the site have already gone to market.

Key takeaways

The ZYN plant in Aurora is still under construction, but shipments have already begun; the first products were made locally in September 2025.
The project represents an investment of about $600 million and is located in the Sun Empire development near the intersection of 56th Avenue and Harvest Road.
Construction began in late 2024 on a site of roughly 150 acres, with infrastructure work continuing.

2Firsts, Feb 10, 2026

According to 9NEWS, Philip Morris International (PMI) is still building its ZYN nicotine pouch manufacturing facility in Aurora, Colorado, but the first pouches produced at the site have already reached the market.

The report said PMI hosted a media tour, during which company representatives brought reporters into two buildings at the site to show how ZYN nicotine pouches are being produced. PMI said the first ZYN products were manufactured at the Aurora facility in September 2025 and have since gone to market.

The project is valued at about $600 million and is located in Aurora’s Sun Empire industrial development, near the intersection of 56th Avenue and Harvest Road. Construction began in late 2024. The report noted the site covers roughly 150 acres and that infrastructure work remains ongoing, with large portions of the main building still under construction. PMI did not disclose what percentage of the facility has been completed.

Cover image source: 9NEWS

References:

[1] $600M Colorado factory starts Zyn pouch production

Also Read:

[1] PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion

[2] Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com